Raouf A. Khalil

Gender-Based Research Underscores Sex Differences in Biological Processes, Clinical Disorders and Pharmacological Interventions.

C. Kelleher, Sofia R. Bernstein, Raouf A. Khalil, 2023, Biochemical pharmacology.

Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy

Aditiawarman, Ernawati, J. Tanus-Santos, 2018, Hypertension in pregnancy.

Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

R. Khalil, H. C. Ringvold, Raouf A. Khalil, 2017, Advances in pharmacology.

Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

R. Khalil, V. B. Gencel, M. M. Benjamin, 2012, Mini reviews in medicinal chemistry.

Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1-7)/MasR signaling in normal and hypertensive pregnancy.

Raouf A. Khalil, Caroline R. Clark, 2023, Biochemical pharmacology.

Changes of the serum properties and its effect on the endothelial cells restoration in patients with chronic disease treated with sulodexide.

J. Raffetto, Tomasz Urbanek, Raouf A. Khalil, 2024, Journal of vascular surgery. Venous and lymphatic disorders.

PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation.

K. Morgan, R. Khalil, Raouf A. Khalil, 1993, The American journal of physiology.

Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells.

C. L. Wang, K. Morgan, R. Khalil, 1995, Circulation research.

Increased uterine arterial tone, stiffness and remodeling with augmented matrix metalloproteinase-1 and -7 in uteroplacental ischemia-induced hypertensive pregnancy.

Raouf A. Khalil, Chen Lin, Marc Q. Mazzuca, 2024, Biochemical pharmacology.